Synthesis and biological evaluation of unnatural derivatives of narciclasine: 7-aza-nornarciclasine and its N-oxide.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4146675)

Published in Bioorg Med Chem Lett on July 19, 2014

Authors

Sergey Vshyvenko1, Mary Rose Reisenauer2, Snezna Rogelj2, Tomas Hudlicky3

Author Affiliations

1: Department of Chemistry and Centre for Biotechnology, Brock University, St. Catharines, ON L2S 3A1, Canada.
2: Biology Department, New Mexico Institute of Mining and Technology, Socorro, NM 87801, United States.
3: Department of Chemistry and Centre for Biotechnology, Brock University, St. Catharines, ON L2S 3A1, Canada. Electronic address: thudlicky@brocku.ca.

Articles cited by this

Toluene degradation by Pseudomonas putida F1. Nucleotide sequence of the todC1C2BADE genes and their expression in Escherichia coli. J Biol Chem (1989) 6.20

Chemistry, biology, and medicinal potential of narciclasine and its congeners. Chem Rev (2008) 1.61

Total synthesis and biological evaluation of Amaryllidaceae alkaloids: narciclasine, ent-7-deoxypancratistatin, regioisomer of 7-deoxypancratistatin, 10b-epi-deoxypancratistatin, and truncated derivatives. J Org Chem (2002) 1.19

Biological evaluation of ent-narciclasine, ent-lycoricidine, and certain enantiomerically-related congeners. Chem Biodivers (2009) 1.14

Synthesis and biological activity of some structural modifications of pancratistatin. Bioorg Med Chem Lett (2004) 1.09

Structure-activity relationship analysis of novel derivatives of narciclasine (an Amaryllidaceae isocarbostyril derivative) as potential anticancer agents. J Med Chem (2009) 1.08

Chemoenzymatic synthesis of Amaryllidaceae constituents and biological evaluation of their C-1 analogues. The next generation synthesis of 7-deoxypancratistatin and trans-dihydrolycoricidine. J Org Chem (2010) 1.05

Studies directed towards the refinement of the pancratistatin cytotoxic pharmacophore. Bioorg Med Chem Lett (2001) 1.04

A synthesis of 3-deoxydihydrolycoricidine: refinement of a structurally minimum pancratistatin pharmacophore. Bioorg Med Chem Lett (2005) 1.02

Isolation and structural modification of 7-deoxynarciclasine and 7-deoxy-trans-dihydronarciclasine. J Nat Prod (2006) 1.02

A beta-carboline-1-one mimic of the anticancer Amaryllidaceae constituent pancratistatin: synthesis and biological evaluation. Angew Chem Int Ed Engl (2004) 0.96

synthesis and biological evaluation of fully functionalized seco-pancratistatin analogues. J Nat Prod (2008) 0.93

Total synthesis of epi-7-deoxypancratistatin via aza-Payne rearrangement and intramolecular cyclization. Org Lett (2002) 0.93

Synthesis and biological evaluation of aromatic analogues of conduritol F, L-chiro-inositol, and dihydroconduritol F structurally related to the amaryllidaceae anticancer constituents. J Org Chem (2006) 0.92

Synthesis of structurally simplified analogues of pancratistatin: truncation of the cyclitol ring. J Org Chem (2009) 0.87

Synthesis of C-1 homologues of pancratistatin and their preliminary biological evaluation. Bioorg Med Chem Lett (2011) 0.85

Synthesis of (+)-lycoricidine by the application of oxidative and regioselective ring-opening of aziridines. Org Lett (2010) 0.84

An intra/intermolecular suzuki sequence to benzopyridyloxepines containing geometrically pure exocyclic tetrasubstituted alkenes. Org Lett (2008) 0.82

Stereospecific biocatalytic synthesis of pancratistatin analogues. Angew Chem Int Ed Engl (2003) 0.82

Application of palladium-catalyzed allylic arylation to the synthesis of a (+/-)-7-deoxypancratistatin analogue. Org Lett (2006) 0.81

Synthesis and evaluation of C-ring aromatized analogues of phenanthridone alkaloids. Arch Pharm Res (2011) 0.78

Synthesis and cytotoxicity of (+/-)-7,9-dideoxy-pancratistatin analogues. Org Biomol Chem (2012) 0.78